• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Study: Acute dengue virus 2 infection in Gabonese patients

Shiloh

Editor, Senior Moderator
Source: http://7thspace.com/headlines/36729...uding_strong_interferon_alpha_production.html

Acute dengue virus 2 infection in Gabonese patients is associated with an early innate immune response, including strong interferon alpha production


Dengue is now a leading cause of morbidity and mortality throughout the tropics. We conducted the first ex vivo study of dengue fever (DF) in African patients infected during the first Gabonese dengue virus 2 (DENV-2) outbreak in 2007, in order to investigate cytokine production, including the antiviral cytokine IFN-alpha, reported to be a potent inhibitor of DENV replication in vitro...

... Conclusion: Acute DENV-2 infection in African patients elicits a strong innate response involving IFN-alpha production, as well as an adaptive immune response.

Author: Pierre BecquartNadia WauquierDieudonne NkogheAngelique Ndjoyi-MbiguinoCindy PadillaMarc SourisEric Leroy
Credits/Source: BMC Infectious Diseases 2010, 10:356
 
Back
Top Bottom